日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma

一种用于预测复发/难治性淋巴瘤患者接受 CAR-T 细胞治疗后严重免疫相关不良事件的循环蛋白特征

Irajizad, Ehsan; Fahrmann, Johannes F; Katayama, Hiroyuki; Strati, Paolo; Nair, Ranjit; Chihara, Dai; Fayad, Luis E; Ahmed, Sairah; Iyer, Swaminathan P; Wang, Michael; Locke, Frederick L; Davila, Marco; Flowers, Christopher R; Shpall, Elizabeth; Neelapu, Sattva S; Hanash, Samir; Westin, Jason; Jain, Michael D; John, Teny M; Saini, Neeraj Y

Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

抗生素引起的肠道微生物群代谢输出下降与CAR-T细胞疗法的临床反应相关

Prasad, Rishika; Rehman, Abdur; Rehman, Lubna; Darbaniyan, Faezeh; Blumenberg, Viktoria; Schubert, Maria-Luisa; Mor, Uria; Zamir, Eli; Schmidt, Sabine; Hayase, Tomo; Chang, Chia-Chi; McDaniel, Lauren; Flores, Ivonne; Strati, Paolo; Nair, Ranjit; Chihara, Dai; Fayad, Luis E; Ahmed, Sairah; Iyer, Swaminathan P; Wang, Michael; Jain, Preetesh; Nastoupil, Loretta J; Westin, Jason; Arora, Reetakshi; Turner, Joel; Khawaja, Fareed; Wu, Ranran; Dennison, Jennifer B; Menges, Meghan; Hidalgo-Vargas, Melanie; Reid, Kayla; Davila, Marco L; Dreger, Peter; Korell, Felix; Schmitt, Anita; Tanner, Mark R; Champlin, Richard E; Flowers, Christopher R; Shpall, Elizabeth J; Hanash, Samir; Neelapu, Sattva S; Schmitt, Michael; Subklewe, Marion; Francois-Fahrmann, Johannes; Stein-Thoeringer, C K; Elinav, Eran; Jain, Michael D; Hayase, Eiko; Jenq, Robert R; Saini, Neeraj Y

Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial

一线治疗高肿瘤负荷晚期滤泡性淋巴瘤:阿卡替尼、来那度胺和利妥昔单抗联合方案:II期试验

Strati, Paolo; Feng, Lei; Westin, Jason R; Nair, Ranjit; Fayad, Luis E; Rodriguez, Maria A; Chihara, Dai; Malpica, Luis; Henderson, Jared; Gallardo, Mariana; Rivera, Marissa; Wang, Iris; Bolshakova, Anastasiia; Radko, Anastasia; Kurtz, David; Alig, Stefan K; Flowers, Christopher R; Alizadeh, Ash A; Neelapu, Sattva S

A Phase I Trial of Evorpacept, Lenalidomide and Rituximab for Patients with B-cell Non-Hodgkin Lymphoma.

Evorpacept、来那度胺和利妥昔单抗治疗 B 细胞非霍奇金淋巴瘤患者的 I 期试验

Strati Paolo, Feng Lei, Tyshevich Andrey, Shavronskaya Darya, Alesse Julia, English Noel, Sheehan Elizabeth, Syzrantsev Nikita, Nesmelov Alexander, Zhuang Tony Z, Chihara Dai, Westin Jason R, Ahmed Sairah, Fayad Luis E, Henderson Jared, Dent Kylie, McChesney Elizabeth, Neelapu Sattva S, Flowers Christopher R

Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas

伊布替尼联合纳武利尤单抗治疗复发性中枢神经系统淋巴瘤患者的二期临床试验

Chihara, Dai; Steiner, Raphael E; Nair, Ranjit; Feng, Lei; Ahmed, Sairah; Strati, Paolo; Malpica, Luis; Griffith, Donna P; Mathew, Shivon A; Montinez, Wirt; Masand, Gita; Samaniego, Felipe; Rodriguez, Maria A; Hagemeister, Fredrick B; Fayad, Luis E; Iyer, Swaminathan P; Nastoupil, Loretta J; Neelapu, Sattva S; Flowers, Christopher R; Westin, Jason R

Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas

嵌合抗原受体T细胞疗法前进行桥接放射治疗对侵袭性大B细胞淋巴瘤患者疗效的影响

Manzar, Gohar S; Pinnix, Chelsea C; Dudzinski, Stephanie O; Marqueen, Kathryn E; Cha, Elaine E; Nasr, Lewis F; Yoder, Alison K; Rooney, Michael K; Strati, Paolo; Ahmed, Sairah; Nze, Chijioke; Nair, Ranjit; Fayad, Luis E; Wang, Michael; Nastoupil, Loretta J; Westin, Jason R; Flowers, Christopher R; Neelapu, Sattva S; Gunther, Jillian R; Dabaja, Bouthaina S; Wu, Susan Y; Fang, Penny Q

Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder

放射疗法在治疗原发性皮肤CD4+小/中T细胞淋巴增殖性疾病中的应用

Wu, Susan Y; Damron, Ethan P; Xu, Jie; Fang, Penny Q; Dai, Julia; Nair, Ranjit; Malpica Castillo, Luis E; Fayad, Luis E; Torres-Cabala, Carlos A; Medeiros, L Jeffrey; Vega, Francisco; Miranda, Roberto N; Duvic, Madeleine; Pinnix, Chelsea C; Dabaja, Bouthaina S; Iyer, Swaminathan P; Huen, Auris O; Gunther, Jillian R

Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial

来那度胺联合奥妥珠单抗治疗复发性惰性非霍奇金淋巴瘤患者的安全性和疗效:一项单组、开放标签、1/2期试验

Gurumurthi, Ashwath; Chin, Collin K; Feng, Lei; Fowler, Nathan H; Strati, Paolo; Hagemeister, Fredrick B; Fayad, Luis E; Westin, Jason R; Obi, Chizobam; Arafat, Janine; Nair, Ranjit; Steiner, Raphael E; Neelapu, Sattva S; Flowers, Christopher R; Nastoupil, Loretta J

Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy

延迟细胞输注对接受嵌合抗原受体T细胞疗法治疗的大B细胞淋巴瘤患者的影响

Jallouk, Andrew P; Kui, Naishu; Sun, Ryan; Westin, Jason R; Steiner, Raphael E; Nair, Ranjit; Nastoupil, Loretta J; Fayad, Luis E; Zaki, Ajlan Al; Hawkins, Misha; Adkins, Sherry; Noorani, Mansoor; Das, Kaberi; Henderson, Jared; Shpall, Elizabeth J; Kebriaei, Partow; Ramdial, Jeremy; Flowers, Christopher R; Neelapu, Sattva S; Ahmed, Sairah; Strati, Paolo

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study

伊布替尼联合利妥昔单抗和来那度胺治疗既往未接受治疗的滤泡性淋巴瘤和边缘区淋巴瘤的安全性和有效性:一项开放标签的 II 期研究

Gordon, Max J; Feng, Lei; Strati, Paolo; Lee, Hun Ju; Hagemeister, Fredrick B; Westin, Jason R; Samaniego, Felipe; Marques-Piubelli, Mario L; Vega Vazquez, Francisco; Parra Cuentas, Edwin R; Solis-Soto, Luisa M; Ma, Wencai; Wang, Jing; Claret, Linda; Averill, Barbara; Ibanez, Karina; Fayad, Luis E; Flowers, Christopher R; Green, Michael R; Davis, R Eric; Neelapu, Sattva S; Fowler, Nathan H; Nastoupil, Loretta J